Of note, SARS-CoV-2-specific CD8+ T cell responses are undetectable in approximately 30% of convalescent COVID-19 cases, even when testing the full SARS-CoV-2 ORFeome of epitopes (22). The gene discussed is CD8A; the disease is COVID-19.